Cargando…
CDK8/19 inhibition plays an important role in pancreatic β-cell induction from human iPSCs
BACKGROUND: Transplantation of differentiated cells from human-induced pluripotent stem cells (hiPSCs) holds great promise for clinical treatments. Eliminating the risk factor of malignant cell transformation is essential for ensuring the safety of such cells. This study was aimed at assessing and m...
Autores principales: | Sakuma, Kensuke, Tsubooka-Yamazoe, Noriko, Hashimoto, Kiyohiro, Sakai, Nozomu, Asano, Shinya, Watanabe-Matsumoto, Saori, Watanabe, Takeshi, Saito, Bunnai, Matsumoto, Hirokazu, Ueno, Hikaru, Ito, Ryo, Toyoda, Taro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814340/ https://www.ncbi.nlm.nih.gov/pubmed/36600289 http://dx.doi.org/10.1186/s13287-022-03220-4 |
Ejemplares similares
-
Characterization and reduction of non-endocrine cells accompanying islet-like endocrine cells differentiated from human iPSC
por: Hiyoshi, Hideyuki, et al.
Publicado: (2022) -
Microhomology-assisted scarless genome editing in human iPSCs
por: Kim, Shin-Il, et al.
Publicado: (2018) -
Rho-Associated Kinases and Non-muscle Myosin IIs Inhibit the Differentiation of Human iPSCs to Pancreatic Endoderm
por: Toyoda, Taro, et al.
Publicado: (2017) -
Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014) -
iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)